Arovella Therapeutics Limited (ASX:ALA)
Australia · Delayed Price · Currency is AUD 0.0490
-0.0020 (-3.92%)
Oct 22, 2026, 3:02 PM AEDT
Arovella Therapeutics Market Cap
Arovella Therapeutics has a market cap or net worth of 59.23 million as of October 21, 2026. It is the 31,709th most valuable company in the world and the 736th biggest in Australia. Its market cap has decreased by 46.21% in one year.
Market Cap
59.23M
Enterprise Value
44.88M
Revenue
3.50M
Global Rank
Country Rank
#736 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since January 24, 2002, Arovella Therapeutics's market cap has increased from 17.67M to 59.23M, an increase of 235.13%. That is a compound annual growth rate of 5.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 59.23M | -46.98% |
| Dec 31, 2025 | 111.71M | -37.97% |
| Dec 31, 2024 | 180.10M | 72.28% |
| Dec 29, 2023 | 104.54M | 574.83% |
| Dec 30, 2022 | 15.49M | -17.41% |
| Dec 31, 2021 | 18.76M | 22.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Recce Pharmaceuticals | 107.02M |
| Nyrada | 105.23M |
| Island Pharmaceuticals | 97.71M |
| LTR Pharma | 85.67M |
| Prescient Therapeutics | 66.34M |
| Neurizon Therapeutics | 62.01M |
| Alterity Therapeutics | 61.86M |
| Avecho Biotechnology | 54.09M |